Changes in influenza-associated excess mortality in China between 2012–2019 and 2020–2021: a population-based statistical modelling study

Abstract Background The seasonal cycle of the influenza virus causes substantial morbidity and mortality globally. The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the circulation of influenza viruses can influence influenza-associated excess mortality. Given the few stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaowei Deng, Jiangmei Liu, Minghan Wang, Nana Chen, Feiran Hao, Juan Yang, Maigeng Zhou, Hongjie Yu
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Infectious Diseases of Poverty
Subjects:
Online Access:https://doi.org/10.1186/s40249-025-01323-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849685870101135360
author Xiaowei Deng
Jiangmei Liu
Minghan Wang
Nana Chen
Feiran Hao
Juan Yang
Maigeng Zhou
Hongjie Yu
author_facet Xiaowei Deng
Jiangmei Liu
Minghan Wang
Nana Chen
Feiran Hao
Juan Yang
Maigeng Zhou
Hongjie Yu
author_sort Xiaowei Deng
collection DOAJ
description Abstract Background The seasonal cycle of the influenza virus causes substantial morbidity and mortality globally. The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the circulation of influenza viruses can influence influenza-associated excess mortality. Given the few studies that have explored this topic, the objective of this study was to evaluate influenza-associated excess mortality in the Chinese mainland from 2012 to 2021 and quantify the changes from 2020 to 2021 compared with 2012–2019. Methods Using data from national influenza surveillance report and disease surveillance points, we fitted a generalized additive model on all-cause (AC), pneumonia & influenza (P&I), and respiratory (R) mortality rates. In this model, we included data of influenza activity (A/H1N1, A/H3N2 and B), temperature, absolute humidity, the COVID-19 pandemic, and time trends. The excess mortality was estimated by subtracting the fitted baseline mortality from the predicted mortality, which set influenza activity to zero. Results The respiratory mortality model explained more than 90% of the variance, indicating the good performance. We found that the influenza-associated mortality was generally decreasing from 2020 to 2021, for instance, influenza A/H1N1-associated excess respiratory mortality (ERM) decreased from 2.62 per 100,000 persons (95% confidence interval: 0.16–5.21) to 0.31 (0.02–0.60) in the northern region and from 3.79 (0.09–7.05) to 0.24 (0.02–0.46) in the southern region between 2012–2019 and 2020–2021. A similar pattern was observed for A/H3N2-associated ERM. While the influenza B remained similar scale, for instance, the ERM was 2.90 (0.72–4.3) and 2.26 (1.76–2.76) in the southern region between 2012–2019 and 2020–2021, respectively. Distinct pattern was observed for the AC and P&I outcomes. Conclusions The COVID-19 pandemic has reduced influenza-associated excess mortality, which may be a result of the reduced activity of the influenza virus caused by nonpharmaceutical interventions. Different patterns of regional differences differed for influenza-associated AC, P&I and R mortality. It should be noticed that the contribution of influenza B was generally similar when comparing 2012–2019 and 2020–2021, which highlighted the attention on the influenza B activity. Additional studies are needed to explore the changes in influenza-associated excess mortality afterwards.
format Article
id doaj-art-f82b68d0a0e54663bdb41ce29a7a7099
institution DOAJ
issn 2049-9957
language English
publishDate 2025-06-01
publisher BMC
record_format Article
series Infectious Diseases of Poverty
spelling doaj-art-f82b68d0a0e54663bdb41ce29a7a70992025-08-20T03:22:57ZengBMCInfectious Diseases of Poverty2049-99572025-06-0114111010.1186/s40249-025-01323-7Changes in influenza-associated excess mortality in China between 2012–2019 and 2020–2021: a population-based statistical modelling studyXiaowei Deng0Jiangmei Liu1Minghan Wang2Nana Chen3Feiran Hao4Juan Yang5Maigeng Zhou6Hongjie Yu7Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan UniversityNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and PreventionShanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan UniversityShanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan UniversityShanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan UniversityShanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan UniversityNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and PreventionShanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan UniversityAbstract Background The seasonal cycle of the influenza virus causes substantial morbidity and mortality globally. The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the circulation of influenza viruses can influence influenza-associated excess mortality. Given the few studies that have explored this topic, the objective of this study was to evaluate influenza-associated excess mortality in the Chinese mainland from 2012 to 2021 and quantify the changes from 2020 to 2021 compared with 2012–2019. Methods Using data from national influenza surveillance report and disease surveillance points, we fitted a generalized additive model on all-cause (AC), pneumonia & influenza (P&I), and respiratory (R) mortality rates. In this model, we included data of influenza activity (A/H1N1, A/H3N2 and B), temperature, absolute humidity, the COVID-19 pandemic, and time trends. The excess mortality was estimated by subtracting the fitted baseline mortality from the predicted mortality, which set influenza activity to zero. Results The respiratory mortality model explained more than 90% of the variance, indicating the good performance. We found that the influenza-associated mortality was generally decreasing from 2020 to 2021, for instance, influenza A/H1N1-associated excess respiratory mortality (ERM) decreased from 2.62 per 100,000 persons (95% confidence interval: 0.16–5.21) to 0.31 (0.02–0.60) in the northern region and from 3.79 (0.09–7.05) to 0.24 (0.02–0.46) in the southern region between 2012–2019 and 2020–2021. A similar pattern was observed for A/H3N2-associated ERM. While the influenza B remained similar scale, for instance, the ERM was 2.90 (0.72–4.3) and 2.26 (1.76–2.76) in the southern region between 2012–2019 and 2020–2021, respectively. Distinct pattern was observed for the AC and P&I outcomes. Conclusions The COVID-19 pandemic has reduced influenza-associated excess mortality, which may be a result of the reduced activity of the influenza virus caused by nonpharmaceutical interventions. Different patterns of regional differences differed for influenza-associated AC, P&I and R mortality. It should be noticed that the contribution of influenza B was generally similar when comparing 2012–2019 and 2020–2021, which highlighted the attention on the influenza B activity. Additional studies are needed to explore the changes in influenza-associated excess mortality afterwards.https://doi.org/10.1186/s40249-025-01323-7Influenza-associated excess mortalityGeneralized additive modelExcess respiratory mortalityAll cause deathPneumonia and influenzaChina
spellingShingle Xiaowei Deng
Jiangmei Liu
Minghan Wang
Nana Chen
Feiran Hao
Juan Yang
Maigeng Zhou
Hongjie Yu
Changes in influenza-associated excess mortality in China between 2012–2019 and 2020–2021: a population-based statistical modelling study
Infectious Diseases of Poverty
Influenza-associated excess mortality
Generalized additive model
Excess respiratory mortality
All cause death
Pneumonia and influenza
China
title Changes in influenza-associated excess mortality in China between 2012–2019 and 2020–2021: a population-based statistical modelling study
title_full Changes in influenza-associated excess mortality in China between 2012–2019 and 2020–2021: a population-based statistical modelling study
title_fullStr Changes in influenza-associated excess mortality in China between 2012–2019 and 2020–2021: a population-based statistical modelling study
title_full_unstemmed Changes in influenza-associated excess mortality in China between 2012–2019 and 2020–2021: a population-based statistical modelling study
title_short Changes in influenza-associated excess mortality in China between 2012–2019 and 2020–2021: a population-based statistical modelling study
title_sort changes in influenza associated excess mortality in china between 2012 2019 and 2020 2021 a population based statistical modelling study
topic Influenza-associated excess mortality
Generalized additive model
Excess respiratory mortality
All cause death
Pneumonia and influenza
China
url https://doi.org/10.1186/s40249-025-01323-7
work_keys_str_mv AT xiaoweideng changesininfluenzaassociatedexcessmortalityinchinabetween20122019and20202021apopulationbasedstatisticalmodellingstudy
AT jiangmeiliu changesininfluenzaassociatedexcessmortalityinchinabetween20122019and20202021apopulationbasedstatisticalmodellingstudy
AT minghanwang changesininfluenzaassociatedexcessmortalityinchinabetween20122019and20202021apopulationbasedstatisticalmodellingstudy
AT nanachen changesininfluenzaassociatedexcessmortalityinchinabetween20122019and20202021apopulationbasedstatisticalmodellingstudy
AT feiranhao changesininfluenzaassociatedexcessmortalityinchinabetween20122019and20202021apopulationbasedstatisticalmodellingstudy
AT juanyang changesininfluenzaassociatedexcessmortalityinchinabetween20122019and20202021apopulationbasedstatisticalmodellingstudy
AT maigengzhou changesininfluenzaassociatedexcessmortalityinchinabetween20122019and20202021apopulationbasedstatisticalmodellingstudy
AT hongjieyu changesininfluenzaassociatedexcessmortalityinchinabetween20122019and20202021apopulationbasedstatisticalmodellingstudy